|
|
Post by myocat on Oct 11, 2021 14:45:48 GMT -5
It's another down day. I am ready for small position and I hope it will trend down to below $3.
|
|
|
|
Post by veritasfiliatemporis on Oct 12, 2021 15:00:25 GMT -5
When you don't have arguments better attack first... ZYESAMI™ still there anyway
|
|
|
|
Post by sellhighdrinklow on Oct 14, 2021 7:45:39 GMT -5
|
|
|
|
Post by sr71 on Oct 14, 2021 8:31:24 GMT -5
And NRXP is at $12.02 in pre-market. Good prospects for MNKD price increase over the next couple of days. |
|
|
|
Post by sr71 on Oct 14, 2021 9:25:10 GMT -5
But of course, the 26 million shares short and the large block of Oct 15 $5 Calls are still working as an anchor suppressing a significant immediate price increase. At least until Tyvaso DPI PDUFA news.
|
|
|
|
Post by winner on Oct 16, 2021 11:41:58 GMT -5
Post I cut from another board.
I do not know if it is legit or not. I am of the opinion that MannKind would have released a statement, if they were in fact participating in this Germany trial.
Does anybody know, if MannKind has already created a powdered form of Aviptadil or has NRXP partnered with somebody else as well to create a powdered form of aviptadil?
POST - CUT
euroRX Pharmaceuticals published a safety report showing critical care patients who were given Aviptadil in combination with remdesivir saw excellent results in restoring lung function.
Germany recently greenlit a phase-2 trial of an INHALED version of the drug.
|
|
|
|
Post by Clement on Oct 16, 2021 12:16:07 GMT -5
Post I cut from another board. I do not know if it is legit or not. I am of the opinion that MannKind would have released a statement, if they were in fact participating in this Germany trial. Does anybody know, if MannKind has already created a powdered form of Aviptadil or has NRXP partnered with somebody else as well to create a powdered form of aviptadil? POST - CUT euroRX Pharmaceuticals published a safety report showing critical care patients who were given Aviptadil in combination with remdesivir saw excellent results in restoring lung function. Germany recently greenlit a phase-2 trial of an INHALED version of the drug. INHALED by nebulizer, but not dry powder inhaled like the Mannkind product would be. The German phase 2 is probably an extension of the ongoing trials by NRx (or Relief) in other countries. |
|
|
|
Post by boca1girl on Oct 16, 2021 12:16:08 GMT -5
From what I could gather from their product pipeline charts is that the inhaled version is a nebulizer.
|
|
|
|
Post by winner on Oct 16, 2021 12:56:50 GMT -5
thanks for the clarification.....
|
|
|
|
Post by neil36 on Oct 27, 2021 9:35:27 GMT -5
|
|
|
|
Post by boca1girl on Oct 27, 2021 9:56:16 GMT -5
Already posted under the Nrxp thread along with another article published this morning. |
|
|
|
Post by bones1026 on Nov 4, 2021 20:03:03 GMT -5
Already posted under the Nrxp thread along with another article published this morning. FDA rejected their EAU today. |
|
|
|
Post by prcgorman2 on Nov 4, 2021 21:43:41 GMT -5
|
|
|
|
Post by mymann on Nov 4, 2021 23:38:35 GMT -5
|
|
|
|
Post by prcgorman2 on Nov 6, 2021 10:39:49 GMT -5
Kind of seems like docs at CDC/NIH aren’t happy with docs at the FDA in a left hand doesn’t know what the right hand is doing kind of way and are going to push the point (with help from NRXP). I’ll hold my breath. (Get it?) |
|
